Korean patients closer to affordable access for groundbreaking cancer treatment, Enhertu

Antengene initiates Phase II Dose Expansion Study of Claudin 18.2 ADC ATG-022 in China and...

Samsung partners with BrickBio to pioneer advanced molecules and therapies using protein engineering for ADCs